glp 1 agonist benefits EASD 2018: of GIP/GLP-1 receptor co-agonists in T2D Can one drug do it
Description
Glucagon-like peptide 1 (GLP-1) receptor agonists use during pregnancy: safety data from regulatory clinical trials
Nearly 72% of the posts mentioned reduced cravings, less drinking, and other effects related to drinking while taking the drugs, researchers said
Niels Ahlmann Olesen/Ritzau Scanpix
Eli Lilly needed to design a molecule with the right balance of activity at both receptors
doi: 10.1016/S0140-6736(08)61206-4
